Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LiuWeiLuoBi Granule is a traditional Chinese medicine (TCM) compound prescription formulated as granules. It is not the same as the well-known "Liu Wei Di Huang Wan" (Rehmannia Six Formula), but rather appears to be a unique multi-herb formula, likely designed for conditions involving joint pain or neuropathy based on its name ("luo bi" often refers to obstruction of channels and pain in TCM). The specific composition and mechanism of action are not detailed in the provided sources, but by convention with similar TCM granules, it likely acts through anti-inflammatory, antioxidative, and neuroprotective pathways. Such formulas are typically used for chronic musculoskeletal or neurological symptoms within TCM practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on LiuWeiLuoBi Granule.